Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+

NCT04693429 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
Ocular Surface
Ocular Comfort

Interventions

DRUG: Bepotastine Besilate

Sponsor

Laboratorios Sophia S.A de C.V.